Giving a single oral antibiotic dose with Bulkamid urethral bulking.
Official title: Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid
Run by Ohio State University · NCT06706362 · Data updated 2026-11-12
This will see if one dose of oral antibiotics given before Bulkamid urethral bulking lowers early urinary tract infections in people treated for stress‑predominant urinary incontinence.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 138 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | April 15, 2027 |
| Study ends | October 15, 2027 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT06706362 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people evaluated at The Ohio State University who plan to undergo Bulkamid urethral bulking for stress or stress‑predominant mixed urinary incontinence, have a negative preoperative UTI test, and a post‑void residual ≤150 mL.
✕Probably not a fit
Patients with recurrent UTIs, contraindications or allergies to the study antibiotics, those undergoing additional pelvic procedures, or those already on daily antibiotics are unlikely to be eligible or to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults scheduled for Bulkamid urethral bulking are randomized and blinded to receive either a single preoperative oral antibiotic (trimethoprim/sulfamethoxazole or nitrofurantoin based on allergy) or a placebo. The primary outcome is the rate of postoperative urinary tract infection in the immediate postoperative period. Secondary analyses will compare UTI rates and treatment success between patients discharged with an indwelling catheter versus those using intermittent self‑catheterization and will examine whether number of injection sites correlates with outcomes. Patients complete validated symptom and satisfaction questionnaires before the procedure, at 6 weeks, and at 1 year to track symptom improvement and patient satisfaction.
Why it matters
Potential benefit: If successful, giving a single prophylactic oral antibiotic at the time of Bulkamid could reduce early postoperative urinary tract infections and improve recovery.
How similar studies have gone: Perioperative antibiotics have reduced UTI risk in some urologic procedures, but prophylaxis specifically for Bulkamid urethral bulking has limited prior data and is not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Patients evaluated by a pelvic floor specialist (either urogynecologist or urologist) at The Ohio State University with plans to undergo urethral bulking with Bulkamid for stress urinary incontinence or mixed urinary incontinence (stress predominant). * Negative testing for UTI in pre-operative work-up (including either negative urine culture or urine dip negative for infection). * Office evaluation with evidence of SUI either with urodynamic studies (UDS) or positive cough stress test (CST). * Post-void residual volume of 150 mL or less (measured by either catheterization or bladder scan) Exclusion Criteria * Contraindications to both oral antibiotics including antibiotic allergies or significant renal disease * Patient undergoing additional pelvic organ prolapse procedures or other urologic procedures concomitantly * Recurrent UTIs, defined as 3 or more UTIs within the past 12 months or 2 UTIs within the past 6 months * Patients currently taking daily antibiotic prophylaxis for any reason * Non-English speaking patients * Pregnant patients * Pelvic organ prolapse stage greater than 2 * Patients with immunosuppression due to underlying medical conditions * Recent antibiotic treatment within one week of the procedure
Where it's running
-
The Ohio State University Wexner Medical Center OB/GYN Female Pelvic Medicine and Reconstructive Surgery
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Susanne Taege, MD — Ohio State University
- Study coordinator: Susanne Taege, MD
- Email: Susanne.Taege@osumc.edu
- Phone: 614-293-4643
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if increasing running cadence helps stress urinary incontinence in parous runners
This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
Evaluating the impact of different mesh widths in surgery for urinary incontinence
This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.
-
Evaluating postoperative activity restrictions after midurethral sling placement
This study is testing whether patients who have had a midurethral sling procedure for stress urinary incontinence do better with strict activity limits or no limits after surgery.
-
Comparing two procedures for treating stress urinary incontinence during vaginal prolapse repair
This study is testing whether a new type of surgery or an injection is better for helping women with stress urinary incontinence during vaginal prolapse repair.
-
Effectiveness and safety of shorter tapes for urinary incontinence
This study looks at whether shorter surgical tapes for treating urinary incontinence in women can improve their quality of life and have fewer complications compared to longer tapes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.